Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Investors Lend Satori $15 Million, Hoping It Converts To An Alzheimer's Treatment

Feb 22 2012

• By Alex Lash

Related Content

Alzheimer’s Player Satori Wades Into Fray With Mystery Technology – And $22 Million

Jan 12 2009

Lilly To Cease Development Of Alzheimer's Drug

Sep 01 2010

Alzheimer's Start-Ups Face A Discovery And Clinical Crossroads

Jul 01 2010

Related Companies

Satori Pharmaceuticals, Inc.

Elan Corporation

Johnson & Johnson

Pfizer Inc.

Biogen, Inc.

Additional Topics

Business Strategies BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window